留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

青少年血清谷丙转氨酶水平与颈动脉内中膜厚度的关联

黄思思 赵敏 孙嘉鸿 席波

黄思思, 赵敏, 孙嘉鸿, 席波. 青少年血清谷丙转氨酶水平与颈动脉内中膜厚度的关联[J]. 中国学校卫生, 2025, 46(7): 1042-1045. doi: 10.16835/j.cnki.1000-9817.2025193
引用本文: 黄思思, 赵敏, 孙嘉鸿, 席波. 青少年血清谷丙转氨酶水平与颈动脉内中膜厚度的关联[J]. 中国学校卫生, 2025, 46(7): 1042-1045. doi: 10.16835/j.cnki.1000-9817.2025193
HUANG Sisi, ZHAO Min, SUN Jiahong, XI Bo. Association between serum alanine transaminase levels and carotid intima-media thickness in adolescents[J]. CHINESE JOURNAL OF SCHOOL HEALTH, 2025, 46(7): 1042-1045. doi: 10.16835/j.cnki.1000-9817.2025193
Citation: HUANG Sisi, ZHAO Min, SUN Jiahong, XI Bo. Association between serum alanine transaminase levels and carotid intima-media thickness in adolescents[J]. CHINESE JOURNAL OF SCHOOL HEALTH, 2025, 46(7): 1042-1045. doi: 10.16835/j.cnki.1000-9817.2025193

青少年血清谷丙转氨酶水平与颈动脉内中膜厚度的关联

doi: 10.16835/j.cnki.1000-9817.2025193
基金项目: 

国家自然科学基金项目 81673195

国家自然科学基金项目 82173538

国家自然科学基金项目 82204066

山东省自然科学基金青年基金项目 ZR20210H272

详细信息
    作者简介:

    黄思思(2000-),女,安徽淮北人,在读硕士,主要研究方向为儿童心血管健康

    通讯作者:

    孙嘉鸿,E-mail:jiahongsun1990@126.com

    席波,E-mail:xibo2007@126.com

  • 利益冲突声明  所有作者声明无利益冲突。
  • 中图分类号: R179 R543.5 R446.11+2

Association between serum alanine transaminase levels and carotid intima-media thickness in adolescents

  • 摘要:   目的  探讨青少年血清谷丙转氨酶(ALT)水平与颈动脉内中膜厚度(cIMT)的关系,为制定青少年心血管结构异常的早期防控策略提供依据。  方法  数据源于2023年10—11月开展的“桓台儿童心血管健康队列”第3次随访调查数据,共纳入1 153名具有完整信息的健康青少年。采用方差分析比较不同ALT水平组青少年的cIMT,采用多元线性回归分析血清ALT水平与cIMT的关系。  结果  Q1,Q2,Q3 ALT水平组青少年的cIMT[(0.56±0.04)(0.57±0.04)(0.59±0.04)mm]差异有统计学意义(F=3.61,P < 0.01)。调整相关协变量后,多元线性回归分析结果显示,ALT水平与cIMT存在正相关(β=0.18,P < 0.01)。性别亚组分析结果显示,男生与总体结果相似(β=0.19,P < 0.01),而女生中关联无统计学意义(β=0.07,P=0.54)。  结论  青少年血清ALT水平升高会增加血管结构损害的风险,在男生中尤为明显。及早发现并控制血清异常ALT水平有助于减少早期血管结构损害,降低不良心血管事件的发生风险。
    1)  利益冲突声明  所有作者声明无利益冲突。
  • 表  1  不同性别学生基本特征比较(x±s)

    Table  1.   Comparison of basic characteristics of students in different genders(x±s)

    性别 人数 年龄/岁 身高/cm 体重/kg BMI/(kg·m-2) SBP/mmHg DBP/mmHg cIMT/mm ALT/(U·L-1) 每日睡眠时间/h
    603 14.1±1.5 171.1±8.7 67.5±17.1 22.9±4.9 121.4±12.1 61.6±7.5 0.58±0.04 19.6±15.2 7.4±1.3
    550 14.2±1.5 162.4±5.6 58.1±13.0 22.0±4.4 110.8±10.3 61.5±7.1 0.56±0.04 13.4±7.7 7.3±0.9
    总计 1 153 14.1±1.5 167.0±8.5 63.0±16.0 22.4±4.7 116.4±12.5 61.6±7.3 0.57±0.04 16.6±12.6 7.4±1.1
    t -0.45 20.45 10.56 3.41 16.00 0.13 9.82 8.81 0.98
    P 0.65 < 0.01 < 0.01 < 0.01 < 0.01 0.90 < 0.01 < 0.01 0.33
    下载: 导出CSV

    表  2  不同性别学生人口学特征报告率情况

    Table  2.   Report of demographic basic characteristics of students in different genders

    性别 人数 超重肥胖 视屏时间≥2 h/d 体力活动不足 蔬菜摄入不足 水果摄入不足 每周含糖饮料摄入≥1次 父亲过去或现在饮酒 母亲过去或现在饮酒
    603 287(47.6) 98(16.2) 174(28.9) 551(91.4) 567(94.0) 155(25.7) 534(88.6) 218(36.2)
    550 185(33.6) 66(12.0) 273(49.6) 529(96.2) 531(96.6) 88(16.0) 480(87.3) 234(42.5)
    总计 1 153 472(40.9) 164(14.2) 447(38.7) 1 080(93.7) 1 098(95.2) 243(21.1) 1 014(87.9) 452(39.2)
    χ2 22.61 3.92 51.45 10.40 3.47 15.71 0.33 4.67
    P < 0.01 0.05 < 0.01 < 0.01 0.06 < 0.01 0.56 0.03
    :()内数字为检出率或报告率/%。
    下载: 导出CSV

    表  3  不同ALT组间青少年cIMT水平比较/mm

    Table  3.   Comparison of cIMT levels in adolescents among different ALT groups/mm

    ALT分组 男生 女生 总体
    人数 x±s 人数 x±s 人数 x±s
    Q1 204 0.57±0.04 185 0.56±0.04 389 0.56±0.04
    Q2 199 0.57±0.04 182 0.56±0.04 381 0.57±0.04
    Q3 200 0.59±0.04ab 183 0.57±0.04a 383 0.59±0.04ab
    F 47.63 23.44 3.61
    P < 0.01 < 0.01 0.03
    aQ1组比较,bQ2组比较,P < 0.05。
    下载: 导出CSV

    表  4  青少年血清ALT水平与cIMT关联的多元线性回归分析

    Table  4.   Multiple linear regression analysis of the association between serum ALT levels and cIMT in adolescents

    性别 模型1 模型2 模型3
    β 标准误 P β 标准误 P β 标准误 P
    男(n=603) 0.48 0.07 < 0.01 0.23 0.07 < 0.01 0.19 0.07 < 0.01
    女(n=550) 0.42 0.12 < 0.01 0.11 0.12 0.34 0.07 0.12 0.54
    总体(n=1 153) 0.47 0.06 < 0.01 0.22 0.06 < 0.01 0.18 0.05 < 0.01
    :模型1调整性别、年龄;模型2在模型1基础上调整了体重状态、每日睡眠时间、体力活动水平、视屏时间、含糖饮料、蔬菜水果摄入、父/母饮酒状况;模型3在模型2基础上调整了SBP和DBP。
    下载: 导出CSV
  • [1] KALAS M A, CHAVEZ L, LEON M, et al. Abnormal liver enzymes: a review for clinicians[J]. World J Hepatol, 2021, 13(11): 1688-1698.
    [2] ZHOU X D, CAI J, TARGHER G, et al. Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention[J]. Cardiovasc Diabetol, 2022, 21(1): 270-287.
    [3] FAIENZAM F, CHIARITO M, MOLINA-MOLINA E, et al. Childhood obesity, cardiovascular and liver health: a growing epidemic with age[J]. World J Pediatr, 2020, 16(5): 438-445.
    [4] KIM S A, PARK K H, WOO S, et al. Vascular alterations preceding arterial wall thickening in overweight and obese children[J]. J Clin Med, 2022, 11(12): 3520-3530.
    [5] 杨慧. 儿童体脂含量增加与颈动脉内中膜增厚的关联分析及其不同肥胖指标的筛查效果比较[D]. 济南: 山东大学, 2023.

    YANG H. Association between elevated body fat mass and high carotid intima-media thickness, and comparison of screening efficacy of different obesity indices in children[D]. Jinan: Shandong University, 2023. (in Chinese)
    [6] CHAVOSHI V, BARZIN M, EBADINEJAD A, et al. Association of ideal cardiovascular health with carotid intima-media thickness (cIMT) in a young adult population[J]. Sci Rep, 2022, 12(1): 10056-10065.
    [7] SASIDHARAN P S, VIJAYAKUMAR M, BALAKRISHNAN A. Carotid intima medial thickness and its association with cardiometabolic risk factors in children with overweight and obesity: a hospital-based cross-sectional study[J]. Br J Nutr, 2025, 133(4): 456-464.
    [8] KARJOO S. Is there an association of vascular disease and atherosclerosis in children and adolescents with obesity and non-alcoholic fatty liver disease?[J]. Front Pediatr, 2018(6): 345-350.
    [9] 杨丽丽, 张茜, 张艳青, 等. 山东省淄博市桓台儿童心血管健康随访队列设计方案[J]. 中华预防医学杂志, 2020, 54(12): 1461-1464. doi: 10.3760/cma.j.cn112150-20200610-00857

    YANG L L, ZHANG Q, ZHANG Y Q, et al. Design of Huantai children cardiovascular health cohort study in Zibo, Shandong Province[J]. Chin J Prev Med, 2020, 54(12): 1461-1464. (in Chinese) doi: 10.3760/cma.j.cn112150-20200610-00857
    [10] Council on Communications and Media. Media and young minds[J]. Pediatrics, 2016, 138(5): e20162591.
    [11] WHO. Global recommendations on physical activity for health[EB/OL]. (2010-01-01)[2024-09-03]. https://www.who.int/publications/i/item/9789241599979.
    [12] 郭腾, 羊柳, 张茜, 等. 儿童超重肥胖和血压偏高联合作用与左心室肥厚的关联研究[J]. 中华预防医学杂志, 2019, 53(7): 686-691.

    GUO T, YANG L, ZHANG Q, et al. Association of joint effect of overweight/obesity and elevated blood pressure with left ventricular hypertrophy in children[J]. Chin J Prev Med, 2019, 53(7): 686-691. (in Chinese)
    [13] YANG L, BOVET P, LIU Y, et al. Consumption of carbonated soft drinks among young adolescents aged 12 to 15 years in 53 low- and middle-income countries[J]. Am J Public Health, 2017, 107(7): 1095-1100.
    [14] ESPINOSA-HERNANDEZ G, NOEL N E, VASILENKO S A, et al. Associations between parental and adolescent alcohol use: the role of gender and familism support[J]. J Adolesc, 2022, 94(7): 1035-1040.
    [15] 中华人民共和国国家卫生健康委员会. 学龄儿童青少年超重与肥胖筛查: WS/T 586—2018[S]. 北京: 中国标准出版社, 2018.

    National Health Commission of the PRC. Screening for overweight and obesity among school-age children and adolescents: WS/T 586-2018[S]. Beijing: Standards Press of China, 2018. (in Chinese)
    [16] BELLENTANI S, BEDOGNI G, TIRIBELLI C. Liver and heart: a new link?[J]. J Hepatol, 2008, 49(2): 300-302.
    [17] TORUN E, AYDIN S, GOKCE S, et al. Carotid intima-media thickness and flow-mediated dilation in obese children with non-alcoholic fatty liver disease[J]. Turk J Gastroenterol, 2015, 25(1): 92-98.
    [18] MANCO M, BEDOGNI G, MONTI L, et al. Intima-media thickness and liver histology in obese children and adolescents with non-alcoholic fatty liver disease[J]. Atherosclerosis, 2010, 209(2): 463-468.
    [19] JOHANSEN M J, GADE J, STENDER S, et al. The effect of overweight and obesity on liver biochemical markers in children and adolescents[J]. J Clin Endocrinol Metab, 2020, 105(2): 430-442.
    [20] 张茜, 马传伟, 席波. 超重肥胖对高血压学龄儿童左心室肥厚的影响[J]. 中国学校卫生, 2019, 40(6): 815-817. doi: 10.16835/j.cnki.1000-9817.2019.06.007

    ZHANG Q, MA C W, XI B. The effects of overweight and obesity on left ventricular hypertrophy among hypertensive school-aged children[J]. Chin J Sch Health, 2019, 40(6): 815-817. (in Chinese) doi: 10.16835/j.cnki.1000-9817.2019.06.007
    [21] 马淑婧, 杨丽丽, 席波. 高血压儿童青少年肥胖与颈动脉内中膜厚度的关系[J]. 中国学校卫生, 2019, 40(6): 818-819, 823. doi: 10.16835/j.cnki.1000-9817.2019.06.008

    MA S J, YANG L L, XI B. Association between obesity and carotid intima-media thickness in hypertensive children and adolescents[J]. Chin J Sch Health, 2019, 40(6): 818-819, 823. (in Chinese) doi: 10.16835/j.cnki.1000-9817.2019.06.008
    [22] FRASER A, LONGNECKER M P, LAWLOR D A. Prevalence of elevated alanine-aminotransferase (ALT) among US adolescents and associated factors: NHANES 1999-2004[J]. Gastroenterology, 2008, 133(6): 1814-1820.
    [23] RUTIGLIANO I, VINCI R, DE FILIPPO G, et al. Metabolic syndrome, hepatic steatosis, and cardiovascular risk in children[J]. Nutrition, 2017, 36: 1-7.
    [24] MARÍA M, IDOIA L, JONATAN R R. Cardiorespiratory fitness, waist circumference and liver enzyme levels in European adolescents: the HELENA cross-sectional study[J]. J Sci Med Sport, 2017, 20(10): 932-936.
    [25] CHEN S. Association between elevated serum alanine aminotransferase and cardiometabolic risk factors in rural Chinese population: a cross-sectional study[J]. BMC Cardiovasc Disord, 2015, 15: 65-73.
    [26] 刘权仪, 吴新华, 陈章荣. 雌激素对血管、心肌保护性作用的分子机制[J]. 国际心血管病杂志, 2018, 45(4): 204-207. doi: 10.3969/j.issn.1673-6583.2018.04.004

    LIU Q Y, WU X H, CHEN Z R. Molecular mechanisms of estrogen's protective effects on blood vessels and myocardium[J]. Int J Cardiovasc Dis, 2018, 45(4): 204-207. (in Chinese) doi: 10.3969/j.issn.1673-6583.2018.04.004
    [27] CHO E J, HAN K, LEE S P, et al. Liver enzyme variability and risk of heart disease and mortality: a nationwide population-based study[J]. Liver Int, 2020, 40(6): 1292-1302.
    [28] CAI J, ZHANG X J, JI Y X, et al. Nonalcoholic fatty liver disease pandemic fuels the upsurge in cardiovascular diseases[J]. Circ Res, 2020, 126(5): 679-704.
    [29] BADMUS O O, HINDS T D, STEC D E. Mechanisms linking metabolic-associated fatty liver disease (MAFLD) to cardiovascular disease[J]. Curr Hypertens Rep, 2023, 25(8): 151-162.
    [30] DORNAS W, SCHUPPAN D. Mitochondrial oxidative injury: a key player in nonalcoholic fatty liver disease[J]. Am J Physiol Gastrointest Liver Physiol, 2020, 319(3): G400-G411.
    [31] FU S, LIN Y, LUO L, et al. The relationship of serum alanine aminotransferase normal-range levels to arterial stiffness and metabolic syndrome in non-drinkers and drinkers: a Chinese community-based analysis[J]. BMC Gastroenterol, 2017, 17(1): 49-55.
    [32] AFARIDEH M, ARYAN Z, GHAJAR A, et al. Complex association of serum alanine aminotransferase with the risk of future cardiovascular disease in type 2 diabetes[J]. Atherosclerosis, 2016, 254: 42-51.
  • 加载中
表(4)
计量
  • 文章访问数:  7
  • HTML全文浏览量:  7
  • PDF下载量:  0
  • 被引次数: 0
出版历程
  • 收稿日期:  2025-05-07
  • 修回日期:  2025-06-17
  • 网络出版日期:  2025-08-02
  • 刊出日期:  2025-07-25

目录

    /

    返回文章
    返回